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KidneyA Clinical Prediction Score to Guide Referral
of Elderly Dialysis Patients for Kidney
Transplant Evaluation
Ling-Xin Chen1, Michelle A. Josephson2, Donald Hedeker3, Kellie H. Campbell4,
Nicole Stankus2 and Milda R. Saunders5
1Department of Internal Medicine, Section of Transplant Nephrology, University of California Davis, Sacramento, California,
USA; 2Department of Medicine, Section of Nephrology, University of Chicago, Chicago, Illinois, USA; 3Department of Public
Health Sciences, University of Chicago, Chicago, Illinois, USA; 4Department of Medicine, Section of Geriatrics and Palliative
Care Medicine, University of Chicago, Chicago, Illinois, USA; and 5Department of Medicine, Section of Hospital Medicine,
University of Chicago, Chicago, Illinois, USAIntroduction: Dialysis patients aged $70 years derive improved life expectancy through kidney trans-
plantation compared with their waitlisted counterparts, but guidelines are not clear about how to identify
appropriate transplantation candidates. We developed a clinical prediction score to identify elderly dialysis
patients with expected 5-year survival appropriate for kidney transplantation (>5 years).
Methods: Incident dialysis patients in 2006–2009 aged $70 were identified from the United States Renal
Data System database and divided into derivation and validation cohorts. Using the derivation cohort,
candidate variables with a significant crude association with 5-year all-cause mortality were included in a
multivariable logistic regression model to generate a scoring system. The scoring system was tested in the
validation cohort and a cohort of elderly transplant recipients.
Results: Characteristics most predictive of 5-year mortality included age >80, body mass index <18, the
presence of congestive heart failure, chronic obstructive pulmonary disease, immobility, and being
institutionalized. Factors associated with increased 5-year survival were non-white race, a primary cause of
end-stage renal disease other than diabetes, employment within 6 months of dialysis initiation, and
dialysis start via arteriovenous fistula. Five-year mortality was 47% for the lowest risk score group (3.6% of
the validation cohort) and >90% for the highest risk cohort (42% of the validation cohort).
Discussion: This clinical prediction score could be useful for physicians to identify potentially suitable
candidates for kidney transplantation.
Kidney Int Rep (2017) 2, 645–653; http://dx.doi.org/10.1016/j.ekir.2017.02.014
KEYWORDS: elderly; kidney transplant referral; mortality; older adults; USRDS
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NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).P atients over the age of 70 years constitute a rapidlygrowing segment of the end-stage renal disease
(ESRD) population; however, there is no consensus
about which of these patients should be referred for
kidney transplantation. Currently, guidelines do not
include any age cutoff recommendations, and the prac-
tice of patient selection in the elderly population varies
between centers.1 Similar to their younger counter-
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International Reports (2017) 2, 645–653the waitlist, though the survival benefit is delayed
compared with younger patients.2 Transplanted
patients older than 70 do not achieve equal survival
compared with those on the waitlist until 4 months
after transplant and will not achieve equal survival
time until 2 years from kidney transplantation.3 Older
recipients tend to have an increased risk of adverse
events, especially infection.4 Recipients’ baseline car-
diovascular health also significantly impacts posttrans-
plant survival.5 However, older patients exhibit
considerable heterogeneity in comorbidities, functional
status, and life expectancy. Thus, nephrologists and
transplantation specialists are faced with the difficulty
of selecting candidates who will benefit from transplan-
tation from this growing population of older adults.
Prior work examining transplantation candidacy in
the older adults has been limited. Grams et al.6 created a645
n = 159,362
2014 USRDS Dataset
n = 2,709,247
Paents with known dialysis 
start date between 2006 –2009
Age ≥70 at dialysis start
n = 167,333
• Missing Medical Evidence 
2005 Form (n = 3933)
• Missing sex (n = 12)
• Missing BMI (n = 1596)
• Died earlier than or on 
same day as first dialysis 
(n = 33)
• Transplanted (n = 2397)
Derivaon Cohort
n = 79,681
Validaon Cohort
n = 79,681
Figure 1. Flowchart of the study population showing inclusion and
exclusion criteria. BMI, body mass index; USRDS, United States
Renal Data System.
CLINICAL RESEARCH L-X Chen et al.: Prediction Score for Elderly Transplant Referralmultivariable model to examine 3-year transplant sur-
vival in older adults. However, their model was based on
older adults 65 years and older who were listed for
transplantation, which was a preselected population.6
Also, their focus was on posttransplant outcomes,
which is different from survival on dialysis. Recently,
Dusseux et al.7 developed a clinical prediction score
using baseline characteristics of incident dialysis pa-
tients 70 years or older to help nephrologists identify
those elderly dialysis patientswho should be referred for
transplantation. Using the Renal Epidemiology and
Information Network registry, Dusseux et al. examined
3-year mortality risk in the French population and
created a score that identified roughly 20%of the French
elderly population as having 3-year mortality of only
30% and thus suitable for transplant referral. However,
their work cannot be applied to the US dialysis popu-
lation for several reasons. First, the model does not
include race and ethnicity because France does not
collect these data. Second, the majority of France’s ESRD
population uses peritoneal dialysis with different out-
comes than the predominately hemodialysis population
in the United States.8 Third, their score included vari-
ables such as congestive heart failure staging, behavioral
diseases, and liver diseases that are not readily available
in the US registry of dialysis patients. And lastly, they
examined 3-year mortality, whereas the median wait
time for a deceased donor kidney is 4.5 years in the
United States.9 Hence, a scoring system needed to be
created for the US population with a similar goal of
assisting physicians in evaluating patient candidacy for
kidney transplant referral.
The goal of this study was to develop a clinical
prediction score that identifies incident elderly dialysis
patients 70 years or older with a long-term prognosis
appropriate for kidney transplant referral in the United
States. Five-year survival was chosen because it ap-
proximates the median waitlist time for deceased donor
kidneys in the United States.9
METHODS
Population
We used data from the 2014 United States Renal Data
System, which contains information about all patients
with ESRD in the United States. Baseline patient in-
formation collected at the time of dialysis initiation was
derived from the 2005 version of the Medical Evidence
Form 2728.
Our cohort included patients with ESRD in the
United States Renal Data System database who initiated
dialysis between 2006 and 2009 and were 70 years or
older at the time of dialysis initiation. The year range
was chosen to ensure that all patients included in the
cohort had the same version of the Medical Evidence646Form 2728 and a minimum of 5 years of follow-up
information available in the database for 5-year mor-
tality rate determination. Patients were excluded if
they did not have a Medical Evidence Form 2728, died
on the date of dialysis initiation, or if they were
missing information on sex, body mass index (BMI), or
date of first renal service (which was the basis of date of
dialysis initiation). The rest of the patients included in
the cohort did not have any additional missing data.
All patients who received a kidney transplant between
2006 and 2014 but would have otherwise qualified for
the cohort were excluded and placed into a separate
transplant group. The main cohort was then divided
using random number assignment into derivation and
validation cohorts. Figure 1 shows the flowchart of the
study population with inclusions and exclusions.
Data
Baseline information obtained at dialysis initiation from
the Medical Evidence Form 2728 included sex, race/
ethnicity, BMI, primary cause of renal failure,
employment status 6 months before dialysis initiation,
care from a nephrologist before dialysis initiation,
dialysis access/modality, and all listed comorbid con-
ditions (Supplementary Appendix S1). Four age groups
were created: 70–74, 75–79, 80–84, and 85 and above.
Four BMI categories were created: less than 18, 18 to
less than 25, 25 to less than 35, and 35 and above.
Employment status before dialysis initiation was
divided into 3 categories: retired (due to age/preferenceKidney International Reports (2017) 2, 645–653
L-X Chen et al.: Prediction Score for Elderly Transplant Referral CLINICAL RESEARCHor disability), employed (full or part time), and other
(unemployed, homemaker, medical leave of absence,
student). Dialysis access and dialysis modality were
combined to form one indicator variable: peritoneal
dialysis, hemodialysis with fistula, hemodialysis with
graft, and hemodialysis with a catheter.
Outcome
The outcome of interest is all-cause mortality occurring
within 5 years of first dialysis service. Mortality and
survival data are collected in the United States Renal
Data System prospectively through either direct
reporting or linkage with data from the Centers for
Medicare and Medicaid Services, the National Death
Index Files, and the Scientific Registry of Transplant
Recipients.
Statistical Analysis
The derivation and validation cohorts were compared
for their relevant baseline characteristics through chi-
squared testing. The derivation cohort was used to
develop the risk score. First, crude associations between
baseline characteristics and 5-year mortality were
assessed through single-variable logistic regression
models for each baseline characteristic. Characteristics
with a P-value less than 0.01 were then included in a
multiple logistic regression model. Variables in the
multivariable model with insignificant P-values (sig-
nificance defined as P < 0.005) were further excluded.
The model was then tested for multicollinearity through
examination of the variance inflation factor of predictors
within the multivariable model. Potential interactions
between predictors were assessed through the addition
of interaction terms and assessed by the P-value within
the model. The model’s validity was checked through
the Pearson chi-squared and Hosmer-Lemeshow good-
ness-of-fit tests, and through plots of residuals, stan-
dardized residuals, and leverage. Once the final multiple
logistic regression model was defined, a scoring system
was created using the beta coefficients. The smallest
absolute value beta coefficient in the model was identi-
fied. Each predictor’s beta coefficient was then divided
by this smallest beta coefficient’s absolute value and the
result was rounded to the nearest integer.7,10 Positive
integer scores increase mortality risk status, whereas
negative integer scores decrease mortality risk status.
The scores of the derivation cohort were further divided
into 5 groups representing 5 levels of mortality risk. The
score divisions were arrived at based on percent mor-
tality such that the 5-year mortality proportionwas 50%
in the lowest score group, 60% in the second lowest
score group, 70% in the next score group, 80% in the
second highest score group, and 90% in the highest
score group.Kidney International Reports (2017) 2, 645–653The scoring system was then applied to the valida-
tion cohort. Mortality proportions were examined and
compared in each of the 5 risk score strata to assess the
score’s reproducibility to build a calibration curve. To
assess the score’s discriminatory ability, the c-statistic
was computed based on the predicted score and the
actual mortality in the derivation and validation
cohorts. Kaplan-Meier survival curves were con-
structed based on truncated 5-year survival data to
assess how well the score separated the risk cohorts
over time. A separate cohort of transplanted patients
was also used to examine how well the risk score
functioned in this group of patients. The distribution
of scores was examined in this transplant population as
well as 5-year mortality percentage by score category.
The baseline characteristics of the transplanted cohort
were further examined by the score group to determine
which predictors were most influential in this cohort.
Of note, an alternative approach to deriving the
prediction score using a Cox proportional hazards
model was attempted treating time until death as the
outcome. However, the proportional hazards assump-
tion was violated across multiple predictors as well as
in the multivariable model, so this approach was not
adopted for the final score generation.
All statistical analyses were done using Stata MP 14
(StataCorp, College Station, TX).
RESULTS
Baseline Characteristics
A total of 159,362 patients comprised the cohort, which
was divided randomly into 79,681 patients for both the
derivation and validation cohorts (Table 1). The 2
cohorts were well randomized except for a preponder-
ance of peritoneal dialysis patients in the derivation
cohort. The majority of the patients in this elderly
dialysis population were non-Hispanic whites aged
70–79 with diabetes or hypertension as the primary
cause of renal failure. The majority had BMI between 25
and 34, were retired, and were started on dialysis via a
catheter. Their predominant comorbidities were cardiac
or hypertension, and a large minority did not have a
nephrologist care for them before dialysis initiation.
Predictors of 5-Year Mortality
The 5-year mortality occurred in 80% of both the
derivation and validation cohorts. The crude and
multivariable logistic regression analyses resulted in 22
characteristics that were predictive of 5-year mortality,
shown in Table 2. Crude associations for each of the
candidate variables can be found in Supplementary
Table S1.
Table 2 shows the scoring system that was created
based on multivariable logistic regression modeling647
Table 1. Baseline characteristics of the derivation and validation
cohorts
Variable
Derivation cohort
(n [ 79,681)
Validation cohort
(n [ 79,681) P value
Sex, n (%)
Male 43,535 (54.64) 43,037 (54.01) 0.012
Age groups, n (%)
70–74 23,956 (30.06) 24,274 (30.46) 0.073
75–79 24,085 (30.23) 23,759 (29.82)
80–84 19,487 (24.46) 19,292 (24.21)
$85 12,153 (15.25) 12,356 (15.51)
Race/ethnicity, n (%)
Non-Hispanic white 53,295 (66.89) 53,038 (66.56) 0.048
Non-Hispanic black 14,795 (18.57) 15,190 (19.06)
Hispanic 8,076 (10.14) 7,893 (9.91)
Asian 2938 (3.69) 3012 (3.78)
Other 577 (0.72) 548 (0.69)
Primary disease, n (%)
Diabetes 31,398 (39.40) 31,368 (39.37) 0.517
Hypertension 30,483 (38.26) 30,488 (38.26)
Glomerulonephritis 3871 (4.86) 4038 (5.07)
Cystic 713 (0.89) 672 (0.84)
Urologic 1288 (1.62) 1269 (1.59)
Other cause 8237 (10.34) 8168 (10.25)
Unknown cause 3691 (4.63) 3678 (4.62)
BMI, n (%)
<18 2819 (3.54) 2806 (3.52) 0.936
18 to <25 30,867 (38.74) 30,893 (38.77)
25 to <35 37,177 (46.66) 37,093 (46.55)
$35 8818 (11.07) 8889 (11.16)
Employment status before dialysis,
n (%)
Retired 67,705 (84.97) 67,578 (84.81) 0.409
Employed 2540 (3.19) 2631 (3.30)
Other (homemaker, unemployed) 9436 (11.84) 9472 (11.89)
Nephrologist care before dialysis start,
n (%)
Yes 46,747 (58.67) 46,755 (58.68) 0.968
No or unknown 32,934 (41.33) 32,926 (41.32)
Access type/modality, n (%)
Arteriovenous fistula 10,345 (12.98) 10,170 (13.26) <0.001
Arteriovenous graft 3041 (3.82) 2996 (3.91)
Catheter 62,476 (78.41) 62,592 (81.63)
Peritoneal dialysis 3819 (4.79) 921 (1.20)
Comorbidities, n (%)
Congestive heart failure 34,161 (42.87) 34,207 (42.93) 0.816
Atherosclerotic heart disease 24,553 (30.81) 24,649 (30.93) 0.603
Other cardiac disease 18,693 (23.46) 18,842 (23.65) 0.379
Cerebrovascular accident or
transient ischemic attack
9772 (12.26) 9686 (12.16) 0.511
Peripheral vascular disease 14,549 (18.26) 14,478 (18.17) 0.645
Hypertension 40,364 (50.66) 40,119 (50.35) 0.220
Amputation 1752 (2.20) 1730 (2.17) 0.706
Diabetes, insulin 23,626 (29.65) 23,916 (30.01) 0.112
Diabetes, oral meds 11,767 (14.77) 11,628 (14.59) 0.325
Diabetes, no meds 4510 (5.66) 4527 (5.68) 0.854
Diabetic retinopathy 4074 (5.11) 4065 (5.10) 0.918
Chronic obstructive pulmonary
disease
10,287 (12.91) 10,183 (12.78) 0.436
Tobacco 2464 (3.09) 2439 (3.06) 0.717
Cancer 9132 (11.46) 8941 (11.22) 0.131
Toxic nephropathy 260 (0.33) 287 (0.36) 0.248
Table 1. (Continued)
Variable
Derivation cohort
(n [ 79,681)
Validation cohort
(n [ 79,681) P value
Alcohol dependence 440 (0.55) 441 (0.55) 0.973
Drug dependence 67 (0.08) 70 (0.09) 0.798
Inability to ambulate 7792 (9.78) 8022 (10.07) 0.054
Inability to transfer 4165 (5.23) 4336 (5.44) 0.057
Needs assistance with daily activities 13,192 (16.56) 13,338 (16.74) 0.326
Institutionalized 10,194 (12.79) 10,328 (12.96) 0.316
Institutionalized, assisted living 842 (1.06) 852 (1.07) 0.807
Institutionalized, nursing home 8963 (11.25) 9049 (11.36) 0.496
Institutionalized, other 439 (0.55) 486 (0.61) 0.121
Nonrenal congenital abnormality 72 (0.09) 62 (0.08) 0.387
No comorbidities 924 (1.16) 960 (1.20) 0.404
Mortality, n (%)
Died within 5 yr of dialysis start 64,167 (80.53) 64,032 (80.36) 0.394
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648using significant predictors. Positive points indicate a
higher risk of mortality, whereas negative points
indicate a lower risk of mortality. The predictor with
the strongest association with increased mortality was
age 85 or above, which resulted in þ14 points. Other
factors strongly associated with increased mortality
included chronologic age 80 to 84, BMI less than 18,
and being institutionalized. The factors most associated
with reduced mortality were any race other than white,
a primary cause of ESRD other than diabetes, being
employed within 6 months of dialysis initiation, and
having an arteriovenous fistula at dialysis initiation.
Comorbid hypertension (other than as the primary
cause of ESRD) was also found to be associated with
increased 5-year survival.
Scoring System Performance
Table 3 shows the number of patients and the pro-
portion of 5-year mortality outcomes in each score
group in both the derivation and validation cohorts.
The range of scores in the derivation cohort was
from 25 to þ50 with a median of 7 and an SD of 9.86.
The range of scores in the validation cohort was
from 27 to þ51 with a median of 7 and an SD of 9.93.
In the derivation cohort, score group 1 (score # 9)
comprised 3.5% of the cohort and had 51% 5-year
mortality. In the validation cohort, score group 1
comprised 3.6% of the cohort and had 47% 5-year
mortality. Score group 5 (score $ 10) comprised the
largest proportion of both cohorts (42%) and experi-
enced the highest 5-year mortality (more than 90%).
The 2 cohorts had similar numbers of patients in each
score group as well as similar mortality proportions,
indicating good calibration and predictive function of
the scoring system. The c-statistic for the derivation
cohort was 0.71 (95% confidence interval 0.70–0.71),
and the c-statistic for the validation cohort was 0.71Kidney International Reports (2017) 2, 645–653
Table 2. Scoring model generated from the derivation cohort
Variables Beta coefficient Pointsa
Male
Baseline ¼ female 0.14 þ2
Age group
70–74 Baseline
75–79 0.27 þ3
80–84 0.66 þ8
$85 1.18 þ14
Race/ethnicity
Non-Hispanic white Baseline
Non-Hispanic black 0.52 6
Hispanic 0.57 7
Asian 0.73 9
Primary disease
Diabetes Baseline
Hypertension 0.37 4
Glomerulonephritis 0.40 5
Cystic 0.66 8
Urologic 0.55 7
Other cause 0.19 2
Unknown 0.20 2
BMI
25, <35 Baseline
<18 0.71 þ8
$18, <25 0.29 þ3
$35 Nonsignificantb 0
Previous employment
Retired Baseline
Employed 0.30 4
Previous renal care
Nephrologist care Baseline
No nephrologist care 0.10 þ1
Access type/modality
Catheter Baseline
Arteriovenous fistula 0.50 6
Arteriovenous graft 0.27 3
Peritoneal dialysis Nonsignificantb 0
Comorbidities
Congestive heart failure 0.43 þ5
Atherosclerotic heart disease 0.08c þ1
Other cardiac 0.20 þ2
Cerebrovascular accident or temporary vascular accident 0.20 þ2
Peripheral vascular disease 0.15 þ2
Hypertension 0.28 3
Amputation 0.24 þ3
Insulin-dependent diabetes mellitus 0.16 þ2
Chronic obstructive pulmonary disease 0.45 þ5
Tobacco 0.25 þ3
Cancer 0.29 þ3
Immobility 0.36 þ4
Needs assistance w activities of daily living 0.23 þ3
Institutionalized 0.48 þ6
BMI, body mass index.
aPoint values greater than zero confer increased the risk of 5-yr mortality. Point values
less than zero confer the decreased risk of 5-yr mortality.
bNonsignificant categories mean that the beta coefficients in the model were nonsig-
nificant, and hence these categories are considered the same as the baseline category.
cSmallest beta coefficient used to derive the scores.
L-X Chen et al.: Prediction Score for Elderly Transplant Referral CLINICAL RESEARCH(0.71, 0.72), indicating a satisfactory discriminatory
function. The score’s ability to distinguish between
5-year mortality risk groups can also be seen in theKidney International Reports (2017) 2, 645–653Kaplan-Meier plot of survival over the 5-year period by
the cohort and score group (Figure 2). The derivation
and validation cohorts had similar survival curves by
the score group.
Scoring System in the Kidney Transplant
Population
A total of 2397 patients 70 years or older between 2006
and 2009 received a kidney transplant before 2014, the
majority of them before 5 years of dialysis. Of those,
1624 (67.75%) received deceased donor kidney trans-
plants and 603 of them died within 5 years of begin-
ning renal replacement therapy (be that dialysis or
transplantation). When the scoring system was applied
to this cohort of kidney transplant recipients who
would otherwise have qualified for the derivation or
validation cohort, the resulting score distributions
were as can be found in Table 4. The range in scores for
this cohort was 26 toþ28 with a median of 4 and an
SD of 6.42. More than 50% of these patients were in the
lowest 2 score groups (all negative scores) and only 2%
were in the highest score group. The c-statistic for the
prediction of 5-year mortality in this kidney transplant
cohort was 0.60 (95% confidence interval 0.57–0.63).
Figure 3 demonstrates the difference in the distribution
of scores between the transplant cohort and the other 2
cohorts. Whereas the distributions of the derivation
and validation cohorts basically overlap, the distribu-
tion of the transplant cohort is shifted to the left. The
transplanted group generally had fewer comorbidities,
were younger, and had less diabetes than the other 2
cohorts (Supplementary Table S2). They also had much
larger proportions receiving nephrologist care before
dialysis initiation or with hypertension. Figure 4 shows
the Kaplan Meier plot of survival in the transplanted
cohort by the score group, which showed a significant
survival difference between score groups by the log
rank test (P < 0.001).
DISCUSSION
We developed a scoring system to assess 5-year
mortality risk in US incident dialysis patients 70
years or older to determine clinical appropriateness for
transplant referral. The 5-year mortality event rate in
the population was 80%, which is much higher than
that of the general dialysis population in the United
States that has a 5-year mortality event rate of
approximately 60%.11 However, the older ESRD pop-
ulation demonstrated significant variability in mortal-
ity—40% of this population had a 90% 5-year
mortality rate, whereas approximately 3% had a 50%
5-year mortality rate.
Our goal was to identify the group of older
patients who would derive the greatest benefit from649
Table 3. Five-year mortality rates by patients’ risk scores in the derivation and validation cohorts
Score group Actual score
Derivation cohort Validation cohort
Number at risk, n (%) Number of deaths, n (%) Number at risk, n (%) Number of deaths, n (%)
1 # 9 2756 (3.46) 1342 (50.94) 2856 (3.58) 1345 (47.09)
2 8 to 4 6932 (8.70) 4222 (60.79) 6965 (8.74) 4222 (60.62)
3 3 to þ1 12,034 (15.10) 8328 (70.17) 12,045 (15.12) 8328 (69.14)
4 þ2 to þ9 24,691 (30.99) 19,757 (80.42) 24,483 (30.73) 19,757 (80.70)
5 $10 33,268 (41.75) 30,380 (90.93) 33,332 (41.83) 30,380 (91.14)
All 79,681 64,032 (80.53) 79,681 64,032 (80.36)
c-statistic (95% confidence interval) 0.71 (0.70, 0.71) 0.71 (0.71, 0.72)
CLINICAL RESEARCH L-X Chen et al.: Prediction Score for Elderly Transplant Referraltransplantation. A score of 4 or less could be used to
identify patients for transplantation referral. This cutoff
identifies the top 12% (those in score groups 1 and 2) of
older dialysis patients. The first group includes 3.5% of
this population with a 50% 5-year mortality risk and a
second group that contains nearly 9% of this population
with approximately 60% 5-year mortality risk. These
mortality risks are comparable to the 5-year mortality
risk of the general ESRD population that is approxi-
mately 60% for hemodialysis patients.11 Because this
score is a screening tool for referral to transplantation
evaluation, we should aim to be more inclusive rather
than more exclusive. For those falling outside of the
lowest score groups, individual considerations may still
take precedence, especially if most of the score derives
from chronologic age alone rather than other comor-
bidities. Apart from its use in transplant referral,
calculating this prediction score for each individual al-
lows the health professional to have a starting place for
comparison and a framework with which to approach
patients and initiate patient-care discussions.
We found that the characteristics with the strongest
association with 5-year mortality were chronologic age
greater than 80, BMI less than 18, the presence of
congestive heart failure, chronic obstructive pulmo-
nary disease, immobility, or being institutionalized.Figure 2. Kaplan-Meier plot of survival probabilities in the derivation
and validation cohorts by the score group.
650Increasing age, heart failure and chronic obstructive
pulmonary disease have also been correlated with
increased first year mortality in incident dialysis pa-
tients in other countries.12,13 Immobility or institu-
tionalized status has been found to be associated with
mortality in the ESRD or elderly population, and dial-
ysis initiation portends worsening functional status in
institutionalized dialysis patients.7,14 Low BMI has
been found to be correlated with increased mortality
risk in the general white population in the United
States and Switzerland.15,16 It is hypothesized that low
BMI in the general population is an indicator of co-
morbid conditions like cancer or respiratory disease,
though the Swiss study showed that mortality in the
low BMI group is largely due to external causes rather
than comorbid conditions.16 BMI less than 18 has also
been found in retrospective studies of US and European
dialysis patients to be highly correlated with increased
mortality.17 In our study population, BMI less than 25,
which is typically considered the cutoff for normal,
was also found to be associated with increased 5-year
mortality, though the strength of the association was
weaker than that for the BMI less than 18. These
findings are suggestive of the fact that “normal” or
“healthy” BMI of the dialysis population may be
higher than that of the general population. Dialysis
patients are known to experience higher rates of
protein-calorie malnutrition and generally have lower
BMI than their age- and sex-matched controls in the
general population.18 Older adults may be particularly
vulnerable to malnutrition and thus exhibit a moreTable 4. Score distributions and mortality in the cohort of patients
who received a kidney transplant
Score group Actual score
Transplanted cohort
Number at risk, n (%) Number of deaths, n (%)
1 # 9 571 (23.82) 109 (19.09)
2 8 to 4 676 (28.20) 138 (20.41)
3 3 to þ1 712 (29.70) 198 (27.81)
4 þ2 to þ9 385 (16.06) 137 (35.58)
5 $ 10 53 (2.21) 21 (39.62)
All 2397 603 (25.16)
c-statistic (95% confidence
interval)
0.60 (0.57, 0.63)
Kidney International Reports (2017) 2, 645–653
Figure 3. Box-and-whisker plot of score distributions for each
cohort.
L-X Chen et al.: Prediction Score for Elderly Transplant Referral CLINICAL RESEARCHpronounced mortality difference at what are considered
low and normal BMI in the general population.
Furthermore, those with BMI higher than 35 in our
study did not exhibit a significantly different mortality
risk from those with BMI in the 25–35 range. These
findings are consistent with the “obesity paradox”
observed among older patients in the general
population and also corroborated in the dialysis
population.17,19 In fact, studies have shown that
patients who are obese before transplant actually do
better after transplant than those with low BMI,
though they do have higher wound complications.20
The strongest associations to 5-year survival were
any race other than white, a primary cause of ESRD
other than diabetes, being employed within 6 months
of dialysis initiation, and having an arteriovenous fis-
tula at the time of dialysis start. Hypertension was also
predictive of 5-year survival, which is consistent with
other publications’ finding that hypotension, particu-
larly during dialysis, is correlated with worse outcomes
in the ESRD population.21 A Canadian study alsoFigure 4. Kaplan-Meier plot of survival probabilities of the
transplanted cohort from the date of dialysis initiation.
Kidney International Reports (2017) 2, 645–653showed improved 1-year mortality in patients with
hypertension.13 Furthermore, hypertension was pre-
sent in a much higher proportion of the transplanted
cohort, also suggesting that hypertension is associated
with better prognosis. These findings of hypertension
in the dialysis population actually portending better
outcomes will need further delineation to distinguish
the possible mechanism of protection. Patients may be
better able to tolerate dialysis treatments because they
have higher blood pressures. Patients with hyperten-
sion may also be on blood pressure medications that
may protect them against cardiovascular comorbidities.
We also found that older racial and ethnic minority
patients with ESRD all have higher 5-year survival
than white patients. Our work is consistent with prior
research on older adults that shows that compared with
whites, racial and ethnic minorities have greater sur-
vival on dialysis and improved post-transplant
survival.22–24 However, despite improved survival of
older Hispanics, blacks, and Asians compared with
their white counterparts, whites are still over-
represented in the transplanted cohort.
This study has several strengths. It is based on a
large cohort of patients that includes the entire US
dialysis population with a very small percentage
excluded. The characteristics examined are derived
from information readily available to the nephrologist
on a patient’s initiation at their dialysis unit, making
the score applicable to patients who initiate dialysis
and easy to use by nephrologists. The score developed
captures not only baseline demographic and medical
information, but also some information about the
patient’s functional status (mobility, assistance with
activities of daily living), which are increasingly
recognized as important predictors of outcomes in the
elderly population.25,26
Furthermore, although this score is more useful for
potential deceased donor kidney transplant candidates,
it can be applied to older patients with potential living
donors as well as to help prognosticate posttransplant
survival. When applied to the transplanted cohort, our
score had a c-statistic of 0.60 for the prediction of
posttransplant mortality, which is unsurprising
because mortality risk after receipt of a kidney trans-
plant includes different predictors than the current
model. This c-statistic is also similar to the performance
of the Estimated Post Transplant Survival score
currently used to risk stratify potential kidney
recipients, which had a c-statistic of 0.67 to 0.69 in an
external validation study.27 Furthermore, because the
transplantation surgery itself is not without risk, the
scoring system may help identify patients who may not
be able to tolerate the surgery. For example, those
patients in the highest risk score group may need651
CLINICAL RESEARCH L-X Chen et al.: Prediction Score for Elderly Transplant Referralfurther scrutiny to determine their viability for surgi-
cal intervention regardless of the donor type. The use
of this score may also be adjusted in those potential
recipients with living donors such that perhaps an
even more inclusive cutoff may be used to identify
potential recipients to maximize the benefit of trans-
plantation in relation to the risk of surgery for both
recipients and donors.
One potential critique of this study is the exclusion
of the kidney transplant recipients from the derivation
and validation cohorts because their information could
have contributed to a better, more discriminatory
scoring system. However, transplant recipients needed
to be excluded because we used logistic regression
modeling for score development. Although a survival
analysis approach like the Cox proportional hazards
model would have allowed their inclusion through
censoring of transplant patients at the time of trans-
plantation, the data violated the basic proportional
hazards assumption. In addition, the majority of pa-
tients who received transplants were in the lowest 2
score categories. Furthermore, given the small number
of patients in the transplanted cohort (n ¼ 2297)
compared with the number of patients in the derivation
and validation cohorts (n ¼ 159,362), we are confident
that the transplant cohort would have had a very small
effect on the ultimate score model.
This study is limited in that the data used are
derived from the Medical Evidence Form 2728, which
is typically completed by the physician, nurse, or
social worker at the patient’s dialysis unit. The
comorbidities examined are reported in the form of
check boxes, which may be completed with varying
degrees of accuracy.28 Also, because of the check-box
way that comorbidities are listed on the Medical Evi-
dence Form, the severity of certain important comor-
bidities could not be assessed. For example, the degree
of congestive heart failure is not noted, nor the type or
stage of cancer, both of which may preclude trans-
plantation immediately without consideration of any
other characteristic. This form also does not include
potentially relevant information such as behavioral
disorders or liver disease, which may impact survival.7
The lack of granularity in this dataset precludes a very
robust discriminatory ability in the scoring system.
Furthermore, this scoring system does not include
discriminators such as gait speed, frailty, cognitive
impairment, or social support that can be obtained
from a comprehensive geriatric assessment and that
have been found to correlate with mortality.25,29,30
In conclusion, we developed a predictive risk score
to evaluate elderly incident dialysis patients and
determine their suitability for referral for kidney
transplantation. Given the heterogeneity of this patient652group, the score can help broaden referral decisions
and provide a clinical rationale for nonreferral. The
score is not meant to be all encompassing, but aims to
provide guidance for referring physicians and trans-
plant professionals when making important clinical
decisions in a heterogeneous population. Further work
evaluating the performance of this score in a prospec-
tive manner still needs to be done.
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